Ablynx
Proprietary therapeutic proteins for treating life-threatening diseases
115 employees · est. 2001 · Belgium
Y-Biologics
Exploring antibodies, creating novel therapeutics
6 employees · est. 2007 · Daejeon, Korea South
Ablynx is the older company (2001 vs 2007); Ablynx is the larger of the two.
Side-by-Side Comparison
| Metric | Ablynx | Y-Biologics |
|---|---|---|
| Founded | ||
| Founded | 2001 older | 2007 |
| Headquarters | ||
| Headquarters | Belgium | Daejeon, Korea South |
| Employees | ||
| Employees | 115 larger | 6 |
| Industry | ||
| Industry | Not tracked yet | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Acquired | Series Unknown |
| Total Funding | ||
| Total Funding | $4.37B | $30.00B |
| Funding Rounds | ||
| Funding Rounds | 11 | 2 |
| Services | ||
| Services | Not tracked yet | Research and Development, Drug Development, Biotechnology Research, Collaborative Innovation |
| Target Customers | ||
| Target Customers | Not tracked yet | Pharmaceutical Companies, Healthcare Providers, Biotech Researchers, Investors in Life Sciences |
| Taxonomy | ||
| Taxonomy | Nanobodies, Therapeutic Proteins, Single-Domain Antibody Fragments, Inflammation Treatment, Hematology, Immuno-oncology, Oncology, Biotechnology Innovation, Multi-specific Molecules, Drug Development, Proprietary Technologies, Life-threatening Diseases, Acquisition Strategy, Biopharmaceuticals, Targeted Therapies | Antibody Drug Development, Immuno-Oncology, Cytokine Therapeutics, Bispecific Antibody Platform, Antibody Screening, Protein Expression, Cell Line Development, Human Nanobody Screening, Antibody Humanization, Affinity Maturation, Recombinant Protein Production, Stable Cell Line Development, Antibody Optimization, Hybridoma Sequencing, Global Immuno-Chemotherapeutic Market |
| Website | ||
| Website | ablynx.com | ybiologics.com |
About Ablynx
Ablynx, a Sanofi company headquartered in Belgium, is innovating in the biotechnology sector with its development of Nanobodies®. These proprietary therapeutic proteins merge the benefits of conventional antibodies with characteristics of small-molecule drugs to combat life-threatening diseases. Th...
About Y-Biologics
Y-Biologics, with the slogan "Exploring antibodies, creating novel therapeutics", stands out as Korea's leading biotechnology company specializing in antibody drug development. Founded in 2007, Y-Biologics has established robust R&D capabilities, focusing on innovative treatments within the fields o...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Ablynx and Y-Biologics — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Ablynx and Y-Biologics — by email.
Frequently Asked Questions
Compare Ablynx with someone else
Start typing a company name or domain.